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2Aspergillus niger glucoamylase consists mainly of two forms, GAI (from the N-terminus, catal-
ytic domain + linker + starch-binding domain (SBD)) and GAII (catalytic domain + linker).
These domains were shuffled to make RGAI (SBD + linker + catalytic domain), RGAI∆L (SBD
+ catalytic domain), and RGAII (linker + catalytic domain), with domains defined by function
rather than by tertiary structure. In addition, Paenibacillus macerans cyclomaltodextrin glucano-
transferase SBD replaced the closely related A. niger glucoamylase SBD to give GAE. Soluble
starch hydrolysis rates decreased as RGAII ≈ GAII ≈ GAI > RGAI∆L ≈ RGAI ≈ GAE. Insoluble
starch hydrolysis rates were GAI > RGAI∆L > RGAI >> GAE ≈ RGAII > GAII, while insoluble
starch-binding capacities were GAI > RGAI > RGAI∆L > RGAII > GAII > GAE. These results
indicate that: 1) moving the SBD to the N-terminus or replacing the native SBD somewhat
affects soluble starch hydrolysis; 2) SBD location significantly affects insoluble starch binding
and hydrolysis; 3) insoluble starch hydrolysis is imperfectly correlated with its binding by the
SBD; and 4) placing the P. macerans cyclomaltodextrin glucanotransferase SBD at the end of a
linker, instead of closely associated with the rest of the enzyme, severely reduces its ability to
bind and hydrolyze insoluble starch.
Keywords: Aspergillus niger/cyclomaltodextrin glucanotransferase/glucoamylase/Paenibacillus
macerans/shuffling/starch-binding domain
3Introduction
Glucoamylase (1,4-α-D-glucan glucohydrolase, EC 3.2.1.3, GA) is an exo-hydrolase that catal-
yzes the release of β-D-glucose by hydrolyzing α-1,4- and α-1,6-glycosidic linkages at the non-
reducing ends of starch and related oligo- and polysaccharide chains. The most studied GAs are
from Aspergillus awamori and Aspergillus niger, which are identical (Svensson et al., 1983;
Nunberg et al., 1984) and henceforth will be called A. niger GA, since the first species has re-
cently been consolidated into the second. There are two major forms of this enzyme. GAI has
three regions: (1) a catalytic domain containing residues 1–470, which includes an O-glycosylat-
ed region from residues 441 to 470; (2) a linker containing residues 471–508, with mannosyl res-
idues O-linked to many serine and threonine residues both here and in the earlier thirty residues
(Gunnarsson et al., 1984), and (3) a starch-binding domain (SBD) containing residues 509–616,
which can bind insoluble starch. GAII, a proteolysis product from GAI lacking its SBD, has 512
or 514 residues (Svensson et al., 1982, 1986; Nunberg et al., 1984). GAI and GAII can hydro-
lyze soluble substrates equally well (Meagher and Reilly, 1989; Meagher et al., 1989). GAI hy-
drolyzes insoluble starch in addition to soluble starch, but GAII, lacking an SBD, is much less
able to do this (Svensson et al., 1982).
All GAs have fairly homologous catalytic domains (Coutinho and Reilly, 1997). Their ter-
tiary structures are similar, consisting of an (α,α)6 barrel (Aleshin et al., 1992) with a peripheral
thirteenth α-helix present in fungal forms. The active site is located in a well (Aleshin et al.,
1992). GAs from filamentous fungi have linkers of varying primary sequences, decreasing in
length from the roughly forty residues found in GAs from most Aspergillus species to approx-
imately twenty residues in Corticium rolfsii GA (Coutinho and Reilly, 1997).
SBDs are found in carbohydrate-binding module Families 20, 21, 25, and 26 (Coutinho and
Henrissat, 1999a,b). Family 20 members include all SBDs located at the C-termini of GAs, along
with SBDs from cyclomaltodextrin glucanotransferases (EC 2.4.1.19, CGTases, Domain E), α-
amylases (EC 3.2.1.1), β-amylases (EC 3.2.1.2), maltotetraose-forming exo-amylases (EC
43.2.1.60), maltogenic α-amylases (EC 3.2.1.133), and other hydrolases. GA and CGTase SBDs
are quite homologous (Figure 1), with those from α-amylases intermediate to them, suggesting
that perhaps they could be interchanged.
At present, tertiary structures are available for nine Family 20 SBDs (Coutinho and Henris-
sat, 1999a). These structures have no α-helices, containing only β-strands and loops (Figure 2).
Rhizopus oryzae and Arxula adeninivorans GAs have N-terminal Family 21 SBDs. There are
no available tertiary structures of these SBDs.
The functional domain boundaries of A. niger GA are somewhat different than those suggest-
ed by its tertiary structure. For instance, the catalytic domain requires a portion of its glycosylat-
ed region to achieve full secretion and thermostability. In a C-terminal truncation study of GAI,
yeast expressing A. niger GA residues 1–460 had a little activity on a starch-clearing plate but no
measurable secreted GA activity. Forms with residues 1–482 and 1–496 were fully active but
were slightly lower in high-temperature thermostability than wild-type GAI and GAII (Evans et
al., 1990). Furthermore, when residues 466–512, 485–512, and 466–483 were deleted, the GA
resulting from the first deletion was almost undetectible, while the GAs resulting from the sec-
ond and third were expressed extracellularly to about 60% and 20% the activities of wild-type
GAI and GAII, which were essentially equal (Libby et al., 1994). Activities of these latter two
forms on soluble starch were about the same as those of GAI and GAII, while those on insoluble
starch were similar to GAI. However, their thermostabilities were somewhat lower.
The optimal functional binding domains of fusions of the A. niger GA SBD to β-galactosid-
ase expressed in Escherichia coli also contain some of the glycosylated linker region. The SBD
possessed the greatest binding capacity when the last eleven amino acid residues of the glycosyl-
ated region were included. A further addition of fourteen residues or the removal of sixteen
residues causes decreased binding capacity (Chen et al., 1991). This suggests that a 119-residue
SBD is a better functional domain than the 108-residue SBD defined by its tertiary structure.
Therefore, the boundaries of the functional domains used in this research are residues 1–482 for
the catalytic domain and residues 497–616 for the SBD. The role of the remaining fourteen-
5residue glycosylated region (residues 483–496) is unclear except to separate the catalytic and
starch-binding domains.
Given that different GAs have SBDs at either their C- and N-termini, the possibility exists
that A. niger GA may function with its SBD at its N-terminus. In addition, considering that many
GAs and CGTases have similar C-terminal SBDs, it is possible that substitution of a CGTase
SBD for the A. niger GA SBD may yield a functional enzyme. The goals of this project therefore
were to determine whether A. niger GA with its SBD at its N-terminus rather than its C-terminus
and whether A. niger GA with a C-terminal substitution of the Paenibacillus (formerly Bacillus)
macerans CGTase SBD can still hydrolyze soluble starch and bind and hydrolyze insoluble
starch. Although there is no known tertiary structure for the latter, its primary sequence is so
similar to the SBD of Bacillus circulans CGTase (Figure 1) that its tertiary structure should be
almost identical to that of the latter shown in Figure 2.
To achieve these goals, genetic engineering was used to reverse the domain order of GAI and
GAII to give RGAI and RGAII, respectively. In addition, a reduced-linker version of RGAI
(RGAI∆L) was made. Finally, a GAI with a CGTase SBD (GAE) was constructed. All four
rearranged GAs and the wild-type forms, GAI and GAII, were expressed in S. cerevisiae and
purified. The abilities of the purified enzymes to bind insoluble starch and to hydrolyze soluble
and insoluble starch were then compared.
Materials and Methods
Plasmids, strains, and media
Construction and sequencing of GA variants was carried out in plasmid pBS+ from Stratagene.
Plasmid pDS4, expressing a truncated GA designated as GACDO (Suominen et al., 1993), and
the yeast expression vector YEpPM18 (Cole et al., 1988), containing the GAI cDNA from A.
awamori, a gift from Cetus, were sources of GA coding and expression vector sequences. The
plasmid pRE513 (Evans et al., 1990), was used to express GAII. The plasmid pLCGT1 (Lee and
6Tao, 1994), containing the CGTase cDNA from P. macerans, was obtained from Dr. Zivko
Nikolov.
All cloning was done in E. coli TG1 [supE, hsdδ5, thiδ(lac-proAB)F'(traD36, proAB+, lacIq,
lacZ, δM15)]. GAs were expressed by S. cerevisiae strain C468 (α, leu2-3, leu2-112, his3-11,
his3-15, mal–) (Innis et al., 1985), also from Cetus.
E. coli strains were grown in LB + Amp medium (10 g/L Difco Bacto-tryptone, 5 g/L Difco
Bacto-yeast extract, 10 g/L NaCl, pH adjusted to 7.5 with NaOH, with or without 1.5% Difco
agar, and 60 mg/L ampicillin). Yeast strains were grown in SD + His medium (1.7 g/L Difco
yeast nitrogen base without amino acids, 5 g/L ammonium sulfate, 2% glucose, 100 mg/L L-his-
tidine, with or without 1.5% Difco agar).
Reagents, enzymes, and oligonucleotides
Reagents were from Sigma or Fisher. T4 DNA ligase, restriction enzymes, and buffers were pur-
chased from Boehringer Mannheim Biochemicals, Promega Biotech, Stratagene, or New Eng-
land Biolabs. HKTM phosphatase from Epicentre Technologies was used for dephosphorylation.
Acarbose was donated by Miles Laboratories. Maltose, glucose oxidase, and peroxidase were
from Sigma. The Iowa State Nucleic Acid Facility supplied the oligonucleotides used for adap-
tors and sequencing primers.
Construction of plasmids
A cloning scheme for the three domain-reversed GAs consisting of eleven plasmids was neces-
sary to achieve the desired constructs. It was designed to take advantage of existing restriction
sites in the GA gene. Adaptors were synthesized to code for residues 483–496 and 606–616.
They were also used to add restriction sites for subsequent plasmid construction. Unique restric-
tion sites to be added were chosen for compatibility so that one type of sticky end could be re-
annealed to another. The first eight plasmids were constructed in the pBS+ cloning vector. The
last three were constructed in the expression vector portion of YEpPM18 while maintaining the
7pre-pro leader sequence cleavage sites and the terminator.
Constructs were produced in four stages. The first of these was to join adaptors to GA gene
regions to obtain plasmids pCG1 and pCG2. The next stage involved combining coding sequen-
ces from pCG1 and pCG2 with another adaptor, resulting in pCG3, the progenitor to pRGAI.
Deletions were then made to produce pCG4 and pCG5, the progenitors of pRGAI∆L and
pRGAII, respectively. In the final stage, the coding sequences were completed by adding the C-
terminal half of the catalytic domain to pCG3, pCG4, and pCG5 and placing the coding sequen-
ces in the expression vector. The specific details follow, and are also shown on Figure 3.
pCG1. This plasmid, coding for most of the SBD, was produced by a directional three-part
ligation. The synthesized N-terminal EcoRI/NheI adaptor (Adoptor 1) (Figure 4) contained an
internal BssHII site. The NheI/SalI portion of the SBD was derived from YEpPM18. The adaptor
and insert were annealed to the pBS+ vector at the EcoRI and SalI sites. The BssHII site was used
in the final three constructs.
pCG2. This was constructed to place the linker upstream of the N-terminal portion of the cat-
alytic domain. This involved ligation of a XbaI/(BssHII)-synthesized linker (Adoptor 2) (Figure
4) and a YEpPM18-derived coding sequence, BssHII to PstI, for the N-terminal half of the catal-
ytic domain with the pBS+ vector. The cohesive end (BssHII) of Adaptor 2 was coded to leave no
BssHII site after ligation.
pCG2A. This plasmid was the end-product of a spontaneous deletion in pCG2. Inverted
repeat sequences of BamHI, XbaI, and BamHI at the vector/adaptor joint were most likely
responsible for a homologous recombination event.
pCG2B. This was constructed to replace the deleted section. pCG2A was restricted with
EcoRI and SpeI and Adaptor 3 (Figure 4) was inserted. pCG2B then contained a synthetic gly-
cosylated linker region surrounded by engineered XbaI and SpeI sites.
pCG2C. A 5.5-kb EcoRI fragment derived from YEpPM18 was cloned into EcoRI-restricted
and dephosphorylated pCG2B. This step was necessary to achieve complete restriction of the
plasmid with EcoRI and XbaI for pCG3 construction.
8pCG3. The EcoRI/SalI SBD coding region of pCG1 and a SalI/XbaI-synthesized adaptor
(Adoptor 4) (Figure 4) were annealed to EcoRI- and XbaI-restricted pCG2C. This clone yielded
a completed SBD upstream of the N-terminal half of the catalytic domain with the linker region
between them. This is the parent of pRGAI.
pCG4. The progenitor of pRGAI∆L was constructed by restricting pCG3 with XbaI and SpeI
to remove the linker region. The sticky ends were reannealed, destroying both restriction sites.
pCG5. The progenitor of pRGAII was constructed by restricting pCG3 with NheI and XbaI to
remove the SBD. The NheI and XbaI sites were destroyed upon ligation of their cohesive ends.
pRGAI, pRGAI∆L, and pRGAII. The final expression vectors for the domain-reordered GAs
were all constructed by three-part directional cloning. Sequences upstream of the catalytic
domain PstI site were joined to the C-terminal half of the catalytic domain and placed in the
expression vector. This was accomplished by annealing the BssHII/PstI fragments from pCG3,
pCG4, and pCG5 to the PstI/HindIII fragment of pDS4 and the BssHII/HindIII vector portion of
YEpPM18.
GAE. The fusion gene GAE was constructed by using a fragment containing the GAI cDNA,
cleaving it to obtain the GA gene holding residues 1–514, and ligating it to that part of the
CGTase gene containing SBD residues 579–687. Specifically, the fusion gene of GAE was con-
structed by using modified pGEM-7Z(+) (the BstXI site had been destroyed) as a cloning vector.
The small XhoI-EcoRI fragment, which contained the GAI cDNA, of YEpPM18 was inserted
into the modified pGEM-7Z(+) to construct pGEM7m-GA. The big BstXI/EcoRI fragment con-
taining the GA gene from amino acid residues 1–514 of pGEM7m-GA, the small HindIII/EcoRI
fragement (containing the CGT gene from amino acid residues 579–687) of pLCGT1, and a
single-strand adaptor (5’-AGCTGGCG-3’) were ligated to construct pGEM7m-GAE. Then the
small XhoI/HindIII fragment of pGEMm-GAE, containing the fusion gene of GAE, was ligated
to the big XhoI/HindIII fragment of YEpPM18 to reconstruct a yeast expression vector YEpPM-
GAE.
Qiagen columns from Diagen were used for purification of plasmid DNA for fragment prep-
9aration. Electrophoresed DNA fragments were extracted from agarose gels with the GeneClean
product from Bio 101, Inc. Other cloning work was done using standard molecular biology pro-
tocols (Sambrook et al., 1989).
Sequencing
Adaptors were verified by sequencing through the regions containing them. All complete gene
constructs were verified by restriction analysis and DNA sequencing, the latter being done by the
Iowa State Nucleic Acid Facility. The secreted sequences of the four constructed GAs are as
follows:
RGAI: Ala-(497–616)-Ser-Arg-(483–496)-Thr-Ser-Ile-Glu-Gly-Arg-(1–484)-Met-Ala-Tyr
RGAI∆L: Ala-(497–616)-Ser-Ser-Ile-Glu-Gly-Arg-(1–484)-Met-Ala-Tyr
RGAII: Ala-Ala-Arg-(483-496)-Thr-Ser-Ile-Glu-Gly-Arg-(1–484)-Met-Ala-Tyr
GAE: (1–514)-(CGTase 579–687)
Therefore, using domains defined by function, RGAI consists of the SBD followed by the linker
and the catalytic domain, while RGAI∆L is the SBD followed by the catalytic domain, RGAII is
the linker followed by the catalytic domain, and GAE is GAII followed by the CGTase SBD. In
terms of tertiary structure, RGAI consists of the last part of the linker followed by the SBD, then
two short adaptors around the middle of the linker, and finally the catalytic domain with the first
part of the linker. RGAI∆L is the same less one of the adaptors and the middle part of the linker.
RGAII is the middle of the linker, followed by an adaptor, the catalytic domain, and the first part
of the linker. GAE is GAII followed by domain E of CGTase.
Transformation of yeast
S. cerevisiae strain C468 was transformed with the constructed expression plasmids pRGAI,
pRGAI∆L, and pRGAII, as well as with YEpPM18 (wild-type GAI), pRE513 (wild-type GAII),
and pAC1 (negative control) by the lithium acetate method (Ito et al., 1983). It was transformed
with YEpPM-GAE by electroporation. Cells containing expression plasmids were then selected
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by leucine prototrophy, which was conferred by the expression vector.
Starch-clearing plate assay
A starch-clearing plate assay verified GA activity in the resulting yeast strains. Aliquots of 5 mL
of selective yeast medium (SD + His minimal medium) were inoculated with the appropriate
yeast strain and grown at 30°C with shaking. At the end of the exponential phase, when OD600
was about 0.5, equivalent numbers of cells were plated on SD + His medium containing 1%
(w/v) soluble starch. Plates were incubated at 30°C for 5 d and then at 50°C for 5 h. Plates were
stained for 1 min with iodine vapors. Clear halos result around colonies producing active GA.
GA production and purification
GAs were secreted from the yeast strains in shake-flask fermentations. Six liters of selective
yeast medium containing 2% glucose were inoculated with the appropriate yeast strain and shak-
en at 30°C and 160 rpm for 5 d. Cells were removed from the culture by centrifugation. Medium
containing GA was concentrated approximately 20-fold in an Amicon ultrafiltration system.
Concentrate was then diafiltered with three times its volume of wash/diafiltration buffer (0.1 M
NaOAc, pH 4.3/1.5 M NaCl) and then reconcentrated.
GA in the diafiltered concentrate (approximately 120 mL) was purified by acarbose affinity
chromatography (Chen et al., 1994). The loaded column was washed with wash/diafiltration buf-
fer and eluted with 1.7 M Tris-HCl, pH 7.6. Column loading, washing, and elution were monit-
ored with a UV detector. Eluted GA was dialyzed extensively with water and the purified GA
was lyophilized for storage. The entire harvesting, purification, and lyophilization process was
completed in under 32 h, largely at 4°C.
SDS-PAGE of GA
GAs were electrophoresed under standard SDS-PAGE conditions on a Bio-Rad 4–15% Tris-
HCl/2.6% crosslinker linear gradient gel to determine purity and apparent molecular mass. Each
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GA-containing lane was loaded with 7 µg of protein sample, electrophoresed under the suggest-
ed conditions, and stained with Coomassie Blue.
GA concentration
Concentrations of rehydrated GAs were determined by one of two methods. GAs used for SDS-
PAGE and soluble and insoluble starch hydrolysis assays were quantified with the Pierce biocin-
choninic acid kit. GA concentrations in solutions used in the insoluble starch-binding assays
were determined with the Bio-Rad Bradford assay kit. Bovine serum albumin was the reference
standard in both methods.
Soluble starch hydrolysis
Soluble starch substrate was prepared daily by boiling Fisher soluble starch (1.8% w/v) in 50
mM NaOAc, pH 4.4, optimal for GA activity. For each reaction, 1.0 mL of starch substrate was
equilibrated in a 35°C water bath for 5 min, a sufficiently low temperature that no enzyme act-
ivity was lost during the assay. Assays were initiated with 0.2–2 µg of enzyme in a total volume
of 200 µL. At times ranging from 5 to 90 min, 100-µL samples were removed and quenched
with 40 µL of 4 M Tris-HCl, pH 7.0.
Glucose concentrations were determined by the Sigma glucose oxidase/peroxidase/o-dianis-
idine assay kit. Activities were determined from slopes of glucose concentration vs. time plots.
Specific activities were then calculated on IU/mg and kcat bases, where 1 IU is defined as the
enzyme necessary to produce 1 µmol/min glucose at 35°C in a 1.5% soluble starch reaction
mixture. Protein molecular masses were calculated from the number of amino acid residues.
Insoluble starch hydrolysis
Insoluble starch substrate was prepared by suspending 1.8% (w/v) Sigma corn starch in 50 mM
NaOAc, pH 4.4, at 35°C. Reactions were initiated with 4 µg GA solution plus reaction buffer in
200 µL. Reaction mixture samples (150 µL) were taken at 10-min intervals for 1 h and were
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quenched with 60 µL of 4 M Tris-Cl, pH 7.0, before being microfuged to pellet the unreacted
starch. A 140-µL portion of each microfuged sample was removed and analyzed for glucose con-
tent. Activity of GA on insoluble starch was determined from the plot of glucose released over
time and recorded on IU/mg and kcat bases as described above.
Insoluble starch binding
Insoluble starch substrate was prepared by washing Sigma corn starch twice with water. The
water was drawn off by suction and the starch was air-dried for several days, with occasional
repowdering with a mortar and pestle. A 0.2-g/mL stock mixture of the washed starch in 50 mM
NaOAc, pH 4.4, was made fresh for each set of assays and chilled on ice. Chilled GA and buffer
were added to aliquots of the stock mixture, resulting in 0–30 µg of GA in a 0.1 g/mL starch
mixture. Reaction tubes were shaken at 5°C for 30 min. The starch was pelleted by centrifugat-
ion and the supernatant was assayed for mass of unbound GA. Equilibrium binding constants
(Kad) were calculated from the linear slopes of plots of nmol bound GA/g starch vs. nmol un-
bound GA/L solution.
Results and Discussion
Starch-clearing plate assay
Soluble starch hydrolysis was initially characterized by starch-clearing plate assays (Figure 5).
The negative control did not show GA activity. GAI, RGAI, and RGAI∆L produced similarly-
sized cleared zones. The cleared zones from GAII and RGAII were larger than those from the
other GAs, perhaps enhanced by differences in diffusion due to enzyme size. GAE gave a small-
er cleared zone.
SDS-PAGE
Purified GAs were subjected to SDS-PAGE (Figure 6). Apparent molecular masses for GAI,
RGAI, and RGAI∆L are 110 kDa. GAII has an apparent molecular mass of about 90 kDa, with
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that of RGAII being a little lower. GAE had two bands of somewhat greater than 110 kDa and
about 90 kDa, suggesting that in some molecules the SBD was cleaved during processing. These
molecular masses are much higher than the 81.7 and 69.2 kDa found by MALDI-TOF for glycos-
ylated GAI and GAII expressed by S. cerevisiae C468 containing plasmid YEpPM18 (Khan et al.,
2000). GAI and GAII produced from pGAC9, a vector with one-fifth the expression ability of the
YEpPM18-based vector, gave apparent molecular masses of 97 and 87 kDa, respectively, meas-
ured by SDS-PAGE (Innis et al., 1985; Evans et al., 1990). This suggests that SDS-PAGE yields
erroneously high molecular masses for GA forms. YEpPM18 produces GAI of higher molecular
mass than pGAC9 (H.-M. Chen, personal communication), probably caused by more glycosylat-
ion (Innis et al., 1985).
Soluble starch hydrolysis
GA specific activities on soluble starch substrate are compared in Table I. GAII and RGAII have
similar activities based on protein mass, somewhat higher than that of GAI. RGAI, RGAI∆L, and
GAE have similar activities, slightly less than that of GAI. These results generally agree with the
results from the starch-clearing assay. When specific activities are converted to kcat values, diff-
erences between enzyme forms become smaller, these values ranging from 13.6 to 22.7 s–1.
Great variations in GA domain architecture do not affect specific activity on soluble starch
greatly. The GA catalytic domain can hydrolyze soluble starch with an SBD at its C-terminus 20
to 25% faster than when these structures are at its N-terminus. RGAII activity is equivalent to
GAII activity. A possible reason for RGAI and RGAI∆L being slightly less active than GAI is
that an N-terminal SBD may physically inhibit soluble starch hydrolysis. The similarities in kcat
values of GAI and GAII agree with an earlier study (Meagher and Reilly, 1989).
Insoluble starch hydrolysis
GAI, RGAI, and RGAI∆L have high specific activities on insoluble starch (Table I). GAII,
RGAII, and GAE specific activities are much lower. GAs lacking SBDs have 15% or less the
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activity on insoluble starch as those containing SBDs, as earlier shown (Svensson et al., 1982).
GAE activity on insoluble starch is much closer to activities of GAII and RGAII, which lack
SBDs, than it is to those GAs with SBDs. The already-mentioned loss of an SBD in some GAE
molecules (Figure 4) may explain some but not all of its low activity. The very low kcat values of
three GA forms indicate that activity on any soluble starch associated with the insoluble starch
substrate was close to negligible.
It is apparent that the GA domains can cooperate to hydrolyze insoluble starch whether the
SBD is N- or C-terminal to the catalytic domain; however, the former is less effective than the
latter. The positioning of the SBD relative to the catalytic domain affects insoluble starch hydrol-
ysis much more than it affects soluble starch hydrolysis. GAI has 45 and 80% greater activity
than RGAI∆L and RGAI, respectively, on insoluble starch, whereas the differences for soluble
starch hydrolysis are 20 and 25%. Presence of the whole linker in RGAI significantly inhibits
insoluble starch hydrolysis, demonstrated by RGAI∆L possessing 25% more activity than RGAI.
Insoluble starch binding
GAI has the greatest ability to bind insoluble starch, while RGAI and RGAI∆L bind insoluble
starch less strongly. GAE, GAII, and RGAII have very little binding ability (Figure 7, Table I).
The SBD functions with residues at its C-terminus, as demonstrated by the relatively high Kad
values of RGAI and RGAI∆L, 60% and 25% that of GAI, respectively. The position of domains
relative to one another may be responsible for these Kad differences. This is especially true for
RGAI, since it contains the same sequences that GAI does. Possibly the three-dimensional con-
figuration of RGAI interferes with access of starch to the SBD.
The very low ability of GAE to bind insoluble starch, 3% that of GAI, appears to be the main
reason for its low activity on this substrate. The CGTase SBD (Domain E) is not separate from
the rest of the enzyme in its native state, and it is quite possible that its structure is so severely
modified when detached from the other CGTase domains and attached to GA through a linker
that its binding ability is diminished. In addition, as mentioned earlier, not all GA molecules
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retain their fused CGTase SBDs after processing. These factors appear to overcome the fact that
GA and CGTase SBDs in their native states have very similar primary and tertiary structures
(Figures 1 and 2).
Two other studies of CGTase SBD fused to other proteins also bear light on this difference.
Dalmia et al. (1995) fused P. macerans CGTase SBD or the A. niger GA SBD to the C-terminus
of β-galactosidase, finding that both constructs followed Langmuir adsorption isotherms, the
former binding half as much insoluble corn starch but about the same amount of crosslinked
amylose as the latter at high enzyme concentrations. Furthermore, the GA SBD-β-galactosidase
fusion protein has the same Kad as the CGTase SBD-β-galactosidase protein on insoluble corn
starch, but double its value on crosslinked amylose. They explained these results as being caused
by the CGTase SBD being potentially more susceptible to unfolding and proteolysis, countered
in the case of amylose by the greater evolutionary advances of the CGTase SBD toward small-
molecule binding.
In a second study, Ohdan et al. (2000) fused a Bacillus sp. CGTase SBD, with and without
the immediately preceding Domain D, to the C-terminus of a Bacillus subtilis α-amylase not
previously possessing an SBD. The fused protein lacking Domain D hydrolyzed soluble corn
starch at the same rate as the parent α-amylase, while that with Domain D was only one-eighth
as active, apparently because of structural distortion caused by the extra domain. Both fusion
proteins had several times the activity of α-amylase on insoluble corn starch, the form with
Domain D being more active, perhaps because of its role as a linker. No comparison with other
SBDs was made.
In all three cases when CGTase SBDs were fused to other proteins, to GA in this study and to
β-galactosidase and α-amylase earlier, diminished binding and/or activity on either soluble or
insoluble starch was noted. These effects appear to be caused by enhanced susceptibility to prot-
eolysis and to changes in tertiary structure.
Comparison of insoluble starch hydrolysis and binding data
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Consideration of soluble and insoluble starch hydrolysis as well as insoluble starch binding pro-
vides insight into the nature of the cooperative interaction between binding and hydrolysis. When
the three data sets for GAI, RGAI, and RGAI∆L are considered simultaneously, it appears that
the relative positioning of the binding domain to the catalytic domain is an important factor
influencing insoluble starch hydrolysis. The lower ability of RGAI and RGAI∆L than of GAI to
hydrolyze insoluble starch is not mainly the result of one catalytic domain having greater activity
than the other, since RGAI and RGAI∆L both hydrolyze soluble substrate at 80% the rate of
GAI. Nor does their difference in insoluble starch hydrolysis rate appear to be completely correl-
ated with starch-binding ability; in fact, RGAI binds starch over twice as well as RGAI∆L, yet it
hydrolyzes insoluble starch less effectively than RGAI∆L, perhaps because the orientation of its
SBD places the insoluble substrate in a less optimal position for hydrolysis than does the orien-
tation of the RGAI∆L SBD, where no linker is present. Three-dimensional enzyme/substrate
studies would be needed to substantiate this hypothesis.
Furthermore, it may be noted that rates by which GAII, RGAII, and GAE hydrolyze insolu-
ble starch are not well correlated with Kad beyond the fact that they all bind and hydrolyze insol-
uble starch poorly compared to GAI, RGAI, and RGAI∆L.
Conclusions
This study has produced significant information regarding GA structure and function. It is now
clear that the A. niger GA catalytic domain can hydrolyze soluble starch with an SBD attached to
its N-terminus and that the SBD can bind insoluble starch with a catalytic domain attached to its
C-terminus. The results also demonstrate that the catalytic and starch-binding domains can coop-
erate to hydrolyze insoluble starch when their order is reversed from that of wild-type A. niger
GA. In addition, insoluble starch binding does not solely correlate with insoluble starch hydrol-
ysis, as evidenced by the results from GAI, RGAI, and RGAI∆L on one hand and from GAII,
RGAII, and GAE, on the other hand.
17
Acknowledgments
The authors thank James Meade, Zivko Nikolov, and Jayarama Shetty for their generous gifts of
the A. niger GA gene, the P. macerans CGTase gene, and acarbose, respectively. They also
thank Alain Laederach for his help with Figure 2. This project was funded by the U.S. Depart-
ment of Agriculture through its National Research Initiative Competitive Grants Program, by the
U.S. Department of Energy through the Consortium for Plant Biotechnology Research, Inc., and
by Genencor International, Inc.
References
Aleshin, A., Golubev, A., Firsov, L.M. and Honzatko, R.B. (1992) J. Biol. Chem., 267,
19291–19298.
Chen, H.-M., Ford, C. and Reilly, P.J. (1994) Biochem. J., 301, 275–281.
Chen, L., Ford, C., Kusnadi, A. and Nikolov, Z.L. (1991) Biotechnol. Prog., 7, 225–229.
Cole, G.E., McCabe, P.C., Inlow, D., Gelfand, D.H., Ben-Bassat, A., and Innis, M.A. (1988)
Bio/Technology, 6, 417–421.
Coutinho, P.M. and Henrissat, B. (1999a) Carbohydrate-Active Enzymes server at URL:
http://afmb.cnrs-mrs.fr/CAZY
Coutinho, P.M. and Henrissat, B. (1999b) Carbohydrate-active enzymes: an integrated database
approach. In "Recent Advances in Carbohydrate Bioengineering", H.J. Gilbert, G. Davies, B.
Henrissat and B. Svensson eds., The Royal Society of Chemistry, Cambridge, pp. 3–12.
Coutinho, P.M. and Reilly, P.J. (1997) Proteins Struct. Funct. Genet., 29, 334–347.
Dalmia, B.K., Schütte, K. and Nikolov, Z.L. (1995) Biotechnol. Bioeng., 47, 575–584.
Evans, R., Ford, C., Sierks, M., Nikolov, Z. and Svensson, B. (1990) Gene, 91, 131–134.
Gunnarsson, A., Svensson, B., Nilsson, B. and Svensson, S. (1984) Eur. J. Biochem., 145,
463–467.
Innis, M.A., Holland M.J., McCabe, P.C., Cole, G.E., Wittman, V.P., Tal, R., Watt, K.W.K.,
18
Gelfand, D.H., Holland, J.P. and Meade, J.H. (1985) Science, 228, 21–26.
Ito, H., Fukuda, Y., Murata, K. and Kimura, A. (1983) J. Bacteriol., 153, 163–168.
Khan, S.M.A., Reilly, P.J. and Ford, C. (2000) Starch/Stärke, 52, 385–397.
Koradi, R., Billeter, M., and Wüthrich, K. (1996) J. Mol. Graphics, 14, 51–55.
Lee, K.C. and Tao, B.Y. (1994) Starch/Stärke, 46, 67–74.
Libby, C.B., Cornett, C.A.G., Reilly, P.J. and Ford, C. (1994) Protein Eng., 7, 1109–1114.
Meagher, M.M. and Reilly, P.J. (1989) Biotechnol. Bioeng., 34, 689–693.
Meagher, M.M., Nikolov, Z.L. and Reilly, P.J. (1989) Biotechnol. Bioeng., 34, 681–688.
Nunberg, J.H., Meade, J.H., Cole, G., Lawyer, F.C., McCabe, P., Schweickart, V., Tal, R.,
Wittman, V.P., Flatgaard, J.E. and Innis, M.A. (1984) Mol. Cell. Biol., 4, 2306–2315.
Ohdan, K., Kuriki, T., Takata, H., Kaneko, H. and Okada, S. (2000) Appl. Environ. Microbiol.,
66, 3058–3064.
Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning, a Laboratory Manual,
2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
Suominen, I., Ford, C., Stachon, D., Heimo, H., Niederauer, M., Nurmela, H., and Glatz, C.
(1993) Enzyme Microb. Technol., 15, 593–600.
Svensson, B., Pedersen, T.G., Svendsen, I., Sakai, T. and Ottesen, M. (1982) Carlsberg Res.
Commun., 47, 55–69.
Svensson, B., Larsen, K., Svendsen, I. and Boel, E. (1983) Carlsberg Res. Commun., 48,
529–544.
Svensson, B., Larsen, K. and Gunnarsson, A. (1986) Eur. J. Biochem., 154, 497–502.
19
Table I. Specific activities and binding constants of wild-type, domain-reordered, and SBD-
substituted GAs on soluble and insoluble starch.
______________________________________________________________________________
GA form Protein Specific activity Kad
molecular ___________________________________________ (L/g)
mass (Da) Soluble starch Insoluble starch
____________________ _____________________
IU/mg kcat (s
–1) IU/mg kcat (s
–1)
______________________________________________________________________________
GAI 65,790 17.0 ± 1.7 a 18.6 ± 1.9 a 5.98 ± 0.47 a 6.55 ± 0.52 a 0.051 ± 0.002 a
GAII 50,474 24.8 ± 3.1 20.9 ± 2.6 0.27 ± 0.04 0.22 ± 0.03 0.0023 ± 0.0002
RGAI 67,257 13.4 ± 3.0 15.0 ± 3.3 3.24 ± 0.15 3.63 ± 0.17 0.030 ± 0.004
RGAI∆L 65,734 14.3 ± 1.5 15.7 ± 1.6 4.14 ± 0.18 4.54 ± 0.20 0.013 ± 0.0003
RGAII 54,253 25.1 ± 2.5 22.7 ± 2.3 0.62 ± 0.03 0.56 ± 0.03 0.0053 ± 0.0003
GAE 66,283 12.3 ± 1.6 13.6 ± 1.7 0.68 ± 0.08 0.75 ± 0.09 0.0017 ± 0.0001
______________________________________________________________________________
aStandard error.
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Figure captions
Fig. 1. Multiple sequence alignment of GA and CGTase SBDs, arranged manually. SWISS-
PROT designations unless noted. Ax: A. niger X-100 (Q12537); As: Aspergillus shirousami
(P22832); Ak: Aspergillus kawachi (P23176); An: A. niger (P04064); Te: Taleromyces emer-
sonii (GenBank AJ304803); Ao: Aspergillus oryzae (P36914); Nc: Neurospora crassa (P14804);
Hg: Humicola grisea (Q12623); Hr: Hormoconis resinae (Q03045); Cr: Corticium rolfsii
(Q12596); Le: Lentinula edodes (GenBank AF220541); Bc: Bacillus circulans (P43379); Bl:
Bacillus licheniformis (P14014); Pm: P. macerans (P04830); Tt: Thermoanaerobacter thermo-
sulfurogenes (P26827); Bo: Bacillus obensis (P27036); Bb: Brevibacillus brevis (O30565); Gs:
G. stearothermophilus (P31797); Kp: Klebsiella pneumoniae (P08704). *: residues totally con-
served. ●: residues semi-conserved (all residues of similar character less at most one outlier).
Fig. 2. Tertiary structures of the SBDs of (a) A. niger GA (Protein Data Bank 1AC0). (b) B.
circulans 251 CGTase (1CDG); (b) Prepared with MOLMOL (Koradi et al., 1996).
Fig. 3. Complete cloning scheme. B: BamHI; Bs: BssHII; E: EcoRI; H: HindIII; N: NheI; P: PstI;
Sa: SalI; Sp: SpeI; X: XbaI. ( ): nonfunctional site when ligated. Catalytic domain: ;
linker: ; SBD: ; EcoRI–EcoRI spacer: .
Fig. 4. Oligonucleotide sequences of adoptors synthesized to 1) provide N-terminal restriction
sites for the SBD; 2) provide N-terminal restriction sites for the N-terminal half of the catalytic
domain; 3) replace the deleted part of pCG2; 4) complete the C-terminal portion of the SBD.
Fig. 5. Starch-clearing plates showing activities of different GAs on soluble starch.
Fig. 6. SDS-PAGE gels of different GAs.
Fig. 7. Insoluble starch binding to GAI (●), GAII (●), RGAI (▼), RGA1∆L (▼), RGAII (■),
GAE (■).
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             • •  *    • *  *  • • * •  *• *    •             • •   •
Ax GA 508 CTT PTA  VAV TFDL TATTTYGENIYLVGSISQLGDWETSDG IALSADKYTSSNPLWYVTV
As GA 508 CTT PTA  VAV TFDL TATTTYGENIYLVGSISQLGDWETSDG IALSADKYTSSNPPWYVTV
Ak GA 508 CTT PTA  VAV TFDL TATTTYGENIYLVGSISQLGDWETSDG IALSADKYTSSNPLWYVTV
An GA 509 CTT PTA  VAV TFDL TATTTYGENIYLVGSISQLGDWETSDG IALSADKYTSSDPLWYVTV
Te GA 485 CTT PTS  VAV TFDE IVSTSYGETIYLAGSIPELGNWSTASA IPLRADAYTNSNPLWYVTV
Ao GA 481 CQV PTT  VSV TFAV KATTVYGESIKIVGSISQLGSWNPSSA TALNADSYTTDNPLWTGTI
Nc GA 485 CAA DHE  VLV TFNE KVTTSYGQTVKVVGSIARLGNWAPASG LTLSAKQYSSSNPLWSTTI
Hg GA 478 CAD ASE  VYV TFNE RVSTAWGETIKVVGNVPALGNWDTSKA VTLSASGYKSSNPLWSTTI
Hr GA 476 CQ       VSI TFNI NATTYYGENLYVIGNSSDLGAWNIADA YPLSASAYTQDRPLWSAAI
Cr GA 451 PGGSSGS  VEV TFDV YATTVYGQNIYITGDVSELGNWTPANG VALSSANY    PTWSATI
Le GA 442 CGGGPVAQAVSV TFNV DASTLEGQNVYLTGAVDALEDWSTDNA ILLSSANY    PTWSVTV
Bc CGT 579 FEVLSGDQ VSV RFVVNNATTALGQNVYLTGSVSELGNWDPAKA IGPMYNQVVYQYPNWYYDV
Bl CGT 578 FTILSGDQ VSV RFVINNATTALGENIYLTGNVSELGNWTTGAASIGPAFNQVIHAYPTWYYDV
Pm CGT 580 FNVLTGDQ VTV RFLVNQANTNYGTNVYLVGNAAELGSWDPNKA IGPMYNQVIAKYPSWYYDV
Tt CGT 576 INILTGNQ ICV RFVVNNASTVYGENVYLTGNVAELGNWDTSKA IGPMFNQVVYQYPTWYYDV
Bo CGT 568 FEVLTGDQ VSI RFAVNNATTSLGTNLYMVGNVNELGNWDPDQA IGPMFNQVMYQYPTWYYDI
Bb CGT 566 FEVLSGNQ VSV RFAVNNATTNSGTNVYIVGNVSELGNWDPNKA IGPMFNQVMYKYPTWYYDI
Gs CGT 572 FEVLTNDQ VSV RFVVNNATTNLGQNIYIVGNVYELGNWDTSKA IGPMFNQVVYSYPTWYIDV
Kp CGT 521 SDDAENPT VQSINFTCNNGYTISGQSVYIIGNIPQLGGWDLTKA VKISPTQYPQWSASLELP
 •      • ••••        • ••    •                        •
Ax GA TLPA GESFEYKFIRVES DDSVEWES DPNREYTVPQ     ACGESTATVTDTWR 615
As GA TLPA GESFEYKFIRVES DDSVEWES DPNREYTVPQ     ACGESTATVTDTWR 615
Ak GA TLPA GESFEYKFIRVES DDSVEWES DPNREYTVPQ     ACGESTATVTDTWR 615
An GA TLPA GESFEYKFIRIES DDSVEWES DPNREYTVPQ     ACGTSTATVTDTWR 616
Te GA NLPP GTSFEYKFFKNQT DGTIVWED DPNRSYTVPA     YCGQTTAILDDSWQ 592
Ao GA NLPA GQSFEYKFIRVQ  NGAVTWES DPNRKYTVPS     TCGVKSAVQSDVWR 587
Nc GA ALPQ GTSFKYKYVVVNS DGSVKWEN DPDRSYAVGT     DC ASTATLDDTWR 591
Hg GA PIKATGSAVQYKYIKVGT NGKITWES DPNRSITLQTASSAGKCAAQ  TVNDSWR 589
Hr GA PLNA GEVISYQYVRQEDCDQPYIYET  VNRTLTVP      ACGGAAVTTDDAWMGPVGSSGNC 587
Cr GA ALPA DTTIQYKYVNID  GSTVIWEDAISNREITTPA        SGTYTEKDTWDES 554
Le GA DLPG STDVQYKYIKKDG SGTVTWES DPNMEITTPA       NGTYAT NDTWR 545
Bc CGT SVPA GKTIEFKFLKKQ  GSTVTWEG GSNHTFTAP  SS    G  TATINVNWQP 686
Bl CGT SVPA GKQLEFKFFKKN  GATITWEG GSNHTFTTP  TS    G  TATVTINWQ 685
Pm CGT SVPA GTKLDFKFIKKG  GGTVTWEG GGNHTYTTP  ASGV  G  TVTV  DWQN 687
Tt CGT SVPA GTTIQFKFIKKN  GNTITWEG GSNHTYTVP  SSST  G  TVIV  NWQQ 683
Bo CGT SVPA EENLEYKFIKKDS SGNVVWES GNNHTYTTP  ATGT  D  TVLV  DWQ 675
Bb CGT SVPA GKNLEYKYIKKDH NGNVTWQS GNNRTYTSP  ATGT  D  TVIS  NW 672
Gs CGT SVPE GKTIEFKFIKKDS QGNVTWES GSNHVYTTP  TNTT  G  KIIV  DWQN 680
Kp CGT SDLN VEWKCVKRNETNP TANVEWQS GANNQFNSN  DTQT     TNGSF 625
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